Trial Profile
Clinical Trials Insight: 700013053
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 17 May 2006
Price :
$35
*
At a glance
- Drugs Ordesekimab (Primary)
- Indications Inflammation; Lymphoma; Psoriasis; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Genmab
- 17 May 2006 New trial record.